相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Autophagy in cardiomyopathies
Antonia T. L. Zech et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes
Xiaoxue Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity
Xiao Ma et al.
SCIENCE ADVANCES (2020)
Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
Yingying Wang et al.
FRONTIERS IN PHARMACOLOGY (2020)
TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity
Xiaoping Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Joerg Herrmann
NATURE REVIEWS CARDIOLOGY (2020)
CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes
Lei Qi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy
Wilson Nadruz et al.
HEART (2019)
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Chowdhury S. Abdullah et al.
SCIENTIFIC REPORTS (2019)
Tanshinone IIA Restores Dynamic Balance of Autophagosome/Autolysosome in Doxorubicin-Induced Cardiotoxicity via Targeting Beclin1/LAMP1
Xiaoping Wang et al.
CANCERS (2019)
Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity
K. Melodi McSweeney et al.
CELL DEATH DISCOVERY (2019)
The Role of Autophagy in the Heart
Sebastiano Sciarretta et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)
Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth
Mingchuan Li et al.
CIRCULATION (2018)
Considerations and Pitfalls in Selecting the Drug Vehicles for Evaluation of New Drug Candidates: Focus on &ITin vivo&IT Pharmaco-Toxicological Assays Based on the Rotarod Performance Test
Mariana Matias et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2018)
The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
Rita Zilinyi et al.
MOLECULES (2018)
Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity
Aarti Asnani et al.
JCI INSIGHT (2018)
Cre-inducible site-specific recombination in zebrafish oligodendrocytes
Alejandro Pinzon-Olejua et al.
DEVELOPMENTAL DYNAMICS (2017)
Standardized echocardiographic assessment of cardiac function in normal adult zebrafish and heart disease models
Louis W. Wang et al.
DISEASE MODELS & MECHANISMS (2017)
Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy
Jordan J. Bartlett et al.
BIOCHEMICAL JOURNAL (2016)
Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats
Guangzhong Liu et al.
CARDIOVASCULAR THERAPEUTICS (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
Oncocardiology-Past, Present, and Future A Review
Edward T. H. Yeh et al.
JAMA CARDIOLOGY (2016)
Luteolin Attenuates Doxorubicin-Induced Cytotoxicity to MCF-7 Human Breast Cancer Cells
Yasunori Sato et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Autophagy in cardiovascular biology
Sergio Lavandero et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Development of autophagy inducers in clinical medicine
Beth Levine et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Autophagy is essential for cardiac morphogenesis during vertebrate development
Eunmyong Lee et al.
AUTOPHAGY (2014)
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms
Shiwei Deng et al.
BMC CANCER (2014)
Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression
Qinghua Dong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
P53 inhibition exacerbates late-stage anthracycline cardiotoxicity
Wuqiang Zhu et al.
CARDIOVASCULAR RESEARCH (2014)
Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity
Debariya Dutta et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Prevention of Anthracycline-Induced Cardiotoxicity
Pimprapa Vejpongsa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase
Yan Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
A Zebrafish Compound Screen Reveals Modulation of Neutrophil Reverse Migration as an Anti-Inflammatory Mechanism
Anne L. Robertson et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
An Injury-Responsive Gata4 Program Shapes the Zebrafish Cardiac Ventricle
Vikas Gupta et al.
CURRENT BIOLOGY (2013)
Enhanced autophagy ameliorates cardiac proteinopathy
Md. Shenuarin Bhuiyan et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Identification of a candidate therapeutic autophagy-inducing peptide
Sanae Shoji-Kawata et al.
NATURE (2013)
Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes
Tomonori Kawaguchi et al.
CARDIOVASCULAR RESEARCH (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Concurrent detection of autolysosome formation and lysosomal degradation by flow cytometry in a high-content screen for inducers of autophagy
Phillip Hundeshagen et al.
BMC BIOLOGY (2011)
Structural Basis of Atg8 Activation by a Homodimeric E1, Atg7
Nobuo N. Noda et al.
MOLECULAR CELL (2011)
Overexpression of Nrdp1 in the Heart Exacerbates Doxorubicin-Induced Cardiac Dysfunction in Mice
Yuan Zhang et al.
PLOS ONE (2011)
High-resolution cardiovascular function confirms functional orthology of myocardial contractility pathways in zebrafish
Jordan T. Shin et al.
PHYSIOLOGICAL GENOMICS (2010)
Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice
Sachiko Sakurabayashi-Kitade et al.
ATHEROSCLEROSIS (2009)
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Andrea Williams et al.
NATURE CHEMICAL BIOLOGY (2008)
Small molecule regulators of autophagy identified by an image-based high-throughput screen
Lihong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
In vivo drug discovery in the zebrafish
LI Zon et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
An introduction to power and sample size estimation
SR Jones et al.
EMERGENCY MEDICINE JOURNAL (2003)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
GM Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)